Nasdaq- and ASX-listed Piedmont Lithium has reported its financial results for the fourth quarter and full year of 2024, highlighting strong production performance and ongoing strategic growth ...
Prenatal and early life sun exposure is associated with a lower risk for relapse in childhood-onset MS, new findings suggest, ...
Piedmont Lithium Inc. ("Piedmont," the "Company," "we," "our," or "us") (Nasdaq: PLL; ASX: PLL), a leading North American ...
A registry study led by the University of Oulu examined the early-stage treatment of relapsing-remitting multiple sclerosis ...
Ocrevus as a first-line treatment for early relapsing MS is better at delaying disease progression than starting with a less ...
The 'ferryman' that transports souls to the afterlife in Greek mythology may actually be a psychedelic neurochemical in the ...
Discontinuation of first-line DMTs among patients with stable MS for at least 5 years may lead to an increased risk for recurrence.
A study found profound swallowing deficits in SMA type 1 babies, a disease feature of note as disease-modifying treatment ...
A low educational status was associated with longer delays before initiating treatment among relapsing-remitting MS patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback